Amphastar Pharmaceuticals (AMPH) EPS (Basic) Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) EPS (Basic) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.42 Mn | 644.30 Mn | 93.47 Mn | 5.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.21% |
| Mar 31, 2026 | -73.31% |
| Dec 31, 2025 | 29.86% |
| Sep 30, 2025 | -55.10% |
| Jun 30, 2025 | -14.82% |
| Mar 31, 2025 | -41.51% |
| Dec 31, 2024 | 126.05% |
| Sep 30, 2024 | -18.38% |
| Jun 30, 2024 | 42.13% |
| Mar 31, 2024 | 62.43% |
| Dec 31, 2023 | -530.12% |
| Sep 30, 2023 | 210.65% |
| Jun 30, 2023 | 51.57% |
| Mar 31, 2023 | 7.77% |
| Dec 31, 2022 | 67.41% |
| Sep 30, 2022 | -49.14% |
| Jun 30, 2022 | 99.40% |
| Mar 31, 2022 | 522.27% |
| Dec 31, 2021 | 439.42% |
| Sep 30, 2021 | 538.87% |